Skip to main content


  • An international clinical trial is underway on a Western Australian-developed inhaled antibiotic combination for people with cystic fibrosis
  • A preliminary clinical study had shown the treatment is effective in reducing infection and improving lung function
  • Potential for the drug to be used to treat other lung infections in children and adults

Click here to read the Media Release on the Brandon Capital website.